NCT02941445View on ClinicalTrials.gov

Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Polycystic Ovary SyndromeBody Weight
Interventions
DRUG

sitagliptin and metformin

DRUG

Metformin

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER

NCT02941445 - Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss | Biotech Hunter | Biotech Hunter